Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TEX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC9A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CBLC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIK3C2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPS27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TOR1AIP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FITM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CORO1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC729683 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CBR3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM20B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C12orf29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLDN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM126A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC37A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on